Literature DB >> 19326059

Myeloid/NK cell acute leukemia.

Bobin Chen1, Xiaoping Xu2, Meirong Ji1, Guowei Lin1.   

Abstract

Myeloid/NK cell leukemia is distinct entity, being different from the myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia in morphology and immunotypes. The entity is a more mature state than the latter. We reported a typical case with presentation, immunology and cytogenetic results. The patient went to see a doctor with leucocytosis, anemia and thrombocytopenia. There are no superficial lymph nodes and splenohepatomegaly. The morphology of leukemia cells in bone marrow was similar to that of acute promyelocytic leukemia. The leukemia cells express CD13, CD33, CD15, and CD56, not expressing CD34, HLA-DR and CD16. No abnormal cytogenetics were found. The patients were given chemotherapy as acute myeloid leukemia, and got complete remission.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19326059     DOI： 10.1007/s12185-009-0282-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  3 in total

1.  Isolated asymptomatic severe neutropenia as the presentation of myeloid/natural killer cell acute leukemia.

Authors:  M Rubio-Batllés; A C de La Mata; J R Romero Macias; A R Vitaller
Journal:  Haematologica       Date:  2000-03       Impact factor: 9.941

2.  CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.

Authors:  R Suzuki; K Yamamoto; M Seto; Y Kagami; M Ogura; Y Yatabe; T Suchi; Y Kodera; Y Morishima; T Takahashi; H Saito; R Ueda; S Nakamura
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

3.  HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

Authors:  A A Scott; D R Head; K J Kopecky; F R Appelbaum; K S Theil; M R Grever; I M Chen; M H Whittaker; B B Griffith; J D Licht
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113
  3 in total
  3 in total

1.  Myeloid/NK cell acute leukemia with unique blast morphology: de novo or secondary leukemia?

Authors:  Shinsaku Imashuku; Naoko Kudo; Park Sungkyu; Masaya Shinbo; Tatsuya Furukawa; Shigenori Iwae
Journal:  Int J Hematol       Date:  2013-09-18       Impact factor: 2.490

2.  Precursor NK cell lymphoblastic leukemia/lymphoma-report of a case with literature review.

Authors:  Sonal Jain; Rajiv Kumar; Abhishek Purohit; Hara Prasad Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-14       Impact factor: 0.900

3.  Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature.

Authors:  Qanita Sedick; Sultan Alotaibi; Saeed Alshieban; Khalid Ben Naheet; Ghaleb Elyamany
Journal:  Case Rep Oncol       Date:  2017-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.